Structures by: Gathergood N.
Total: 6
C39H43ClCuFN5O4,H2O,CH4O
C39H43ClCuFN5O4,H2O,CH4O
Dalton transactions (Cambridge, England : 2003) (2019) 48, 24 8578-8593
a=8.3938(4)Å b=17.8033(9)Å c=25.5129(11)Å
α=90° β=90° γ=90°
C33H42N2O3Si
C33H42N2O3Si
Organic letters (2003) 5, 6 921-923
a=10.8305(1)Å b=11.1512(2)Å c=13.6330(2)Å
α=91.503(1)° β=108.014(1)° γ=97.261(1)°
4-(Di-tert-butyl-hydroxy-silanyloxy)-2-methyl-5-oxo-2,5-dihydro-furan- -2-carboxylic acid ethyl ester
C16H28O6Si
Organic & biomolecular chemistry (2004) 2, 7 1077-1085
a=12.626(1)Å b=14.332(2)Å c=20.971(2)Å
α=90.000° β=95.257(2)° γ=90.000°
C23H19N3O5
C23H19N3O5
Chem.Commun. (2013) 49, 2341
a=10.2862(8)Å b=20.0798(16)Å c=9.6427(8)Å
α=90.00° β=90.1550(10)° γ=90.00°
Morphine 3-(1-naphthoate)
C28H25N1O4
Acta Crystallographica Section E (2003) 59, 12 o1918-o1919
a=12.7421(2)Å b=7.19080(10)Å c=12.9536(3)Å
α=90° β=111.9000(10)° γ=90°
Morphine di-(naphthalene-1-carboxylate)
C39H31N1O5
Acta Crystallographica Section C (2003) 59, 9 o485-o487
a=7.84350(10)Å b=9.7218(2)Å c=39.5921(9)Å
α=90° β=90° γ=90°